Therapeutic Cancer Vaccines in Combination with Conventional Therapy

Mads Hald Andersen, N. Junker, E. Ellebaek, I.M. Svane, P.T. Straten

    Research output: Contribution to journalJournal articleResearchpeer-review

    811 Downloads (Pure)


    The clinical efficacy of most therapeutic vaccines against cancer has not yet met its promise. Data are emerging that strongly support the notion that combining immunotherapy with conventional therapies, for example, radiation and chemotherapy may improve efficacy. In particular combination with chemotherapy may lead to improved clinical efficacy by clearing suppressor cells, reboot of the immune system, by rendering tumor cells more susceptible to immune mediated killing, or by activation of cells of the immune system. In addition, a range of tumor antigens have been characterized to allow targeting of proteins coupled to intrinsic properties of cancer cells. For example, proteins associated with drug resistance can be targeted, and form ideal target structures for use in combination with chemotherapy for killing of surviving drug resistant cancer cells. Proteins associated with the malignant phenotype can be targeted to specifically target cancer cells, but proteins targeted by immunotherapy may also simultaneously target cancer cells as well as suppressive cells in the tumor stroma.
    Original languageEnglish
    JournalJournal of Biomedicine and Biotechnology
    Pages (from-to)237623
    Publication statusPublished - 2010

    Bibliographical note

    This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


    Dive into the research topics of 'Therapeutic Cancer Vaccines in Combination with Conventional Therapy'. Together they form a unique fingerprint.

    Cite this